Julia A. Hasler

A novel mutant variant of the <i>CYP2D6</i> gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activity

Collen Masimirembwa, I. Persson, Leif Bertilsson et al. · British Journal of Clinical Pharmacology · 1996 · 199 citations · Full text

Effects of Chloroquine Treatment on Antioxidant Enzymes in Rat Liver and Kidney

Tapiwanashe Magwere, Yogeshkumar S. Naik, Julia A. Hasler · Free Radical Biology and Medicine · 1997 · 121 citations

Polyphenolics, Biochemistry, Chloroquine Treatment +13

Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s.

Tashinga E. Bapiro, Ann‐Charlotte Egnell, Julia A. Hasler et al. · PubMed · 2001 · 118 citations

High Throughput, Recombinant Cyps, Fluo/rcyp Assays +18

Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.

John D. Groopman, C. P. Wild, Julia A. Hasler et al. · Environmental Health Perspectives · 1993 · 103 citations · Full text

Molecular Epidemiology, Pathology, Human Epidemiology +17

Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

Collet Dandara, Collen Masimirembwa, Ayoub Magimba et al. · European Journal of Clinical Pharmacology · 2001 · 101 citations

Psychiatry, Psychiatric Disorders, Genetics +10